Search alternatives:
significantly used » significantly reduced (Expand Search), significantly faster (Expand Search), significantly linked (Expand Search)
lower decrease » linear decrease (Expand Search), larger decrease (Expand Search), we decrease (Expand Search)
used increased » use increased (Expand Search), causes increased (Expand Search), cases increased (Expand Search)
teer decrease » mean decrease (Expand Search), greater decrease (Expand Search)
Showing 141 - 160 results of 125,874 for search '(( significantly ((lower decrease) OR (teer decrease)) ) OR ( significantly used increased ))', query time: 0.50s Refine Results
  1. 141
    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells.

    BA attenuated the decrease in the expression of ZO-1 and Occludin induced by LPS in Caco2 cells. by Luqiong Liu (11537092)

    Published 2024
    Save to List
    Saved in:
  2. 142
    A375 melanoma cells are more susceptible to increasing concentrations of hydrogen peroxide and cerium oxide nanoparticles.

    A375 melanoma cells are more susceptible to increasing concentrations of hydrogen peroxide and cerium oxide nanoparticles. by Claudia von Montfort (256730)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  3. 143
    Integration of Metabolomics, Transcriptomics, and 16s rRNA Sequencing Reveals the Mechanism of Morus alba <i>L.</i> (Sangzhi) Alkaloids (SZ-A) in Improving Cholesterol Metabolism in Diabetic Rats

    Integration of Metabolomics, Transcriptomics, and 16s rRNA Sequencing Reveals the Mechanism of Morus alba <i>L.</i> (Sangzhi) Alkaloids (SZ-A) in Improving Cholesterol Metabolism i... by Caina Li (4126462)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  4. 144
    Primers used to quantify the expression of immune, bacterial, and viral genes, as well as genes associated with European foulbrood and two reference genes.

    Primers used to quantify the expression of immune, bacterial, and viral genes, as well as genes associated with European foulbrood and two reference genes. by Maggie Shanahan (17879479)

    Published 2024
    Subjects:
    Save to List
    Saved in:
  5. 145
    GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model.

    GXM decreases the trans-endothelial electrical resistance (TEER) and transmigration of <i>C</i>. <i>neoformans</i> through HBECs in a blood brain barrier (BBB) model. by Hiu Ham Lee (15374677)

    Published 2023
    Save to List
    Saved in:
  6. 146
    Parameter values used in the model (to 3 significant figures).

    Parameter values used in the model (to 3 significant figures). by Nick P. Taylor (11888714)

    Published 2023
    Save to List
    Saved in:
  7. 147
    (Related to Fig 6): NPF in LNd and NPFR in LPN are not required to high-temperature-induced evening sleep decrease.

    (Related to Fig 6): NPF in LNd and NPFR in LPN are not required to high-temperature-induced evening sleep decrease. by Xin Yuan (174619)

    Published 2024
    “…Quantification of evening sleep (H) and sleep change (I) before and after temperature increase. Data (C, F, I) were analyzed using Welch’s one-way ANOVA, and same letter a denote no significant difference. …”
    Save to List
    Saved in:
  8. 148
    Comparison of CBF between the CCH and control groups.

    Comparison of CBF between the CCH and control groups. by Jung-In Lee (1731727)

    Published 2022
    Subjects:
    Save to List
    Saved in:
  9. 149
    Different characterization techniques and their uses.

    Different characterization techniques and their uses. by Shaheer Ahmed Khan (17797647)

    Published 2025
    Subjects:
    Save to List
    Saved in:
  10. 150
    Perioperative factors associated with differences in adjusted hospitalization costs; all displayed factors are significantly associated with increased or decreased adjusted costs.

    Perioperative factors associated with differences in adjusted hospitalization costs; all displayed factors are significantly associated with increased or decreased adjusted costs. by Saad Mallick (17283479)

    Published 2024
    Save to List
    Saved in:
  11. 151
    Trends in YLDs rates and YLLs rates by sex and age strata in China and the USA, 1990–2019, using Joinpoint regression models.

    Trends in YLDs rates and YLLs rates by sex and age strata in China and the USA, 1990–2019, using Joinpoint regression models. by Chengyue Zhang (1346655)

    Published 2023
    Subjects:
    Save to List
    Saved in:
  12. 152
    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period.

    Join-point regression analysis of the statistically significant linear increase in use of antidepressants during the observed time period. by Jelena Filimonovic (22305307)

    Published 2025
    Save to List
    Saved in:
  13. 153
    Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated.

    Kaplan-Meier analysis, patients with CVD and/or hypertension, baseline uncomplicated. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  14. 154
    ACEi or ARB do not affect expression of ACE2 in lung epithelial cells.

    ACEi or ARB do not affect expression of ACE2 in lung epithelial cells. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  15. 155
    Baseline characteristics of patients in the uncomplicated phase of COVID-19.

    Baseline characteristics of patients in the uncomplicated phase of COVID-19. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  16. 156
    Biomarkers in uncomplicated patients with CVD/Hypertension.

    Biomarkers in uncomplicated patients with CVD/Hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  17. 157
    Mortality risk in patients with CVD and hypertension.

    Mortality risk in patients with CVD and hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  18. 158
    Mortality risk in patients with CVD and hypertension—Advanced disease.

    Mortality risk in patients with CVD and hypertension—Advanced disease. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  19. 159
    Biomarkers in all patients with CVD/Hypertension.

    Biomarkers in all patients with CVD/Hypertension. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:
  20. 160
    Baseline characteristics of patients included in the study.

    Baseline characteristics of patients included in the study. by Sebastian Cremer (11592273)

    Published 2021
    Subjects:
    Save to List
    Saved in:

Search Tools: